• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的诊断与治疗(作者译)

[Diagnostics and therapy of the carcinoma of the prostate (author's transl)].

作者信息

Schnorr D, Guddat H M, Neuser D, Correns H J, Dörner G, Mau S

出版信息

Zentralbl Chir. 1979;104(7):436-45.

PMID:112805
Abstract

By well organized preventive examinations early tumour stages can be recognized. The diagnosis of prostatic cancer has to be secured by biopsy. The primary reliability of aspiration biopsies (cytology) was 94% compared with punch biopsies (histology) amounting to 73%. Indications and results of aspiration biopsies, radiological and nuclear medical techniques in diagnosing prostatic cancer are described. The combined anti-androgenic hormonal therapy (infusions of cytonal, subcapsular orchiectomy, permanent administration of oestrogen) is considered to be the unchanged basis of treatment. Comparative cytologic investigations in therapy indicate that high-voltage treatment connected with hormonal therapy seems to be superior to exclusive hormonal treatment. Observations after additional therapy by a radionuclid (89-Strontium) for affecting metastases are encouraging. Indications of a therapy by cytostatica in progressive prostatic cancer are explained.

摘要

通过精心组织的预防性检查,可以识别早期肿瘤阶段。前列腺癌的诊断必须通过活检来确定。穿刺活检(细胞学)的初步可靠性为94%,而打孔活检(组织学)为73%。文中描述了穿刺活检、放射学和核医学技术在诊断前列腺癌方面的适应症和结果。联合抗雄激素激素治疗(静脉输注赛托宁、包膜下睾丸切除术、长期服用雌激素)被认为是治疗的不变基础。治疗中的比较细胞学研究表明,与激素治疗相结合的高压治疗似乎优于单纯的激素治疗。用放射性核素(锶-89)进行辅助治疗以影响转移灶后的观察结果令人鼓舞。文中解释了在进展性前列腺癌中使用细胞抑制剂进行治疗的适应症。

相似文献

1
[Diagnostics and therapy of the carcinoma of the prostate (author's transl)].前列腺癌的诊断与治疗(作者译)
Zentralbl Chir. 1979;104(7):436-45.
2
Current management of prostatic carcinoma.
Prim Care. 1985 Dec;12(4):795-813.
3
[Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)].前列腺癌的睾丸切除术与雌激素疗法(作者译)
Urologe A. 1974 Jul;13(4 Pt A):198-201.
4
The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
Urol Clin North Am. 1994 Nov;21(4):707-15.
5
Evaluation of prostatic cytology in primary diagnosis and clinical course of prostatic carcinoma.前列腺细胞学检查在前列腺癌初步诊断及临床病程中的评估
Prog Clin Biol Res. 1976;6:329-45.
6
[Prostatic cancer, diagnosis and hormonal treatment (author's transl)].[前列腺癌,诊断与激素治疗(作者译)]
Schweiz Rundsch Med Prax. 1974 Feb 5;63(5):120-3.
7
[Transretcat aspiration biopsy in the diagnosis of prostatic cancer (author's transl)].经直肠针吸活检在前列腺癌诊断中的应用(作者译)
Urologe A. 1976 Jan;15(1):13-7.
8
Management of newly diagnosed metastatic carcinoma of the prostate.新诊断前列腺转移性癌的管理
Urol Clin North Am. 1984 May;11(2):283-95.
9
Treatment of stage IV carcinoma of the prostate.
Urol Clin North Am. 1975 Feb;2(1):141-61.
10
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.评估调强放疗联合原位基因治疗加或不加激素治疗前列腺癌的I-II期试验——前列腺特异抗原反应及活检数据中期报告
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1520-9. doi: 10.1016/j.ijrobp.2003.09.083.